PBM Accountability Project Managing Director Mark Blum Joins Pharmacy Podcast Network
- msevcik1
- Oct 4, 2022
- 1 min read
Updated: Oct 17, 2022
Today we are hoping to make sense of the Inflation Reduction Act which is designed to protect Medicare recipients from catastrophic drug costs by phasing in a cap for out-of-pocket costs and establishing a$35 cap for a month's supply of insulin. And, as an historic win, Medicare will be able to negotiate prices for high-cost drugs for the first time ever.